Skip to main content
. 2021 Sep;9(18):1437. doi: 10.21037/atm-21-4227

Figure 3.

Figure 3

Kaplan-Meier curves of patients with two cancer types after ICI treatment, stratified by 10 mutations/Mb TMB value. (A) Colorectal cancer, (B) hepatocellular carcinoma. Patients with >10 mutations/Mb TMB values were defined as the TMB-high group and the other patients were defined as the TMB-low group. P value was obtained from two-sided log-rank test. TMB, tumor mutational burden; ICI, immune checkpoint inhibitor.